ClinicalTrials.gg
Sign In

Gonorrhea clinical trials

The registry lists 167 studies for Gonorrhea across more than 10 countries. 31 are recruiting or about to start. 96 of them are mainly about Gonorrhea (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Gonorrhea studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
108
Recruiting
17
Not yet recruiting
14
Terminated
12
Active, not recruiting
7
Status unknown
7

Phase

Phase 3
23
Phase 4
17
Phase 2
15
Phase 1
12

Where

United States
98
South Africa
9
France
7
Australia
6
United Kingdom
5
Kenya
4

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (17) · University of Washington (8) · University of North Carolina, Chapel Hill (6) · University of California, Los Angeles (5) · University of California, San Francisco (5) · Northwestern University (5) · University of Pittsburgh (4) · Melinta Therapeutics, Inc. (3)

What is being tested here

Drugs under test in Gonorrhea studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Doxycycline314
Ciprofloxacin102
Temocillin111
4CMenB vaccine037
Zoliflodacin015
Cefixime014
Gepotidacin013
Ceftriaxone003
Gentamicins023
Azithromycin013

Coming up

8phase 3 studies under way
9studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 17 Gonorrhea studies recruiting now, 10 (59%) set no upper age limit and 6 (35%) stop at 75 or younger. 10 (59%) take children under 18. 6 (35%) are for women only and 3 (18%) for men only; 12 (71%) take healthy volunteers.

Recruiting studies that take each age, of 17
AgeWomenMen
103 (18%)1 (6%)
1814 (82%)10 (59%)
3011 (65%)8 (47%)
4010 (59%)7 (41%)
5010 (59%)7 (41%)
659 (53%)6 (35%)
759 (53%)6 (35%)
859 (53%)6 (35%)

Across all 167 studies, recruiting or not: 39% stop at 75 or younger and 38% at 65; 42% take children; 26% are for women only and 22% for men only; 65% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gonorrhea studies take

Of 40 interventional studies with no phase under Gonorrhea, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo11–41 · 40 studies—23 mo11–43 · 36 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Results posted1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 167. Browse all 167 → or search them.